Edition:
India

Camurus AB (CAMX.ST)

CAMX.ST on Stockholm Stock Exchange

111.20SEK
23 Jan 2018
Change (% chg)

-- (--)
Prev Close
111.20kr
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
41,560
52-wk High
147.80kr
52-wk Low
103.00kr

Chart for

About

Camurus AB is a Sweden-based research and development based pharmaceutical company with a focus on the development and commercialization of specialty medicines, providing patients suffering from serious and chronic disease, such as opioid dependence, pain, cancer, acromegaly, and neuroendocrine tumors. The Company has a... (more)

Overall

Beta: --
Market Cap(Mil.): kr4,585.62
Shares Outstanding(Mil.): 37.28
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 31.11 16.62
EPS (TTM): -- -- --
ROI: -- 14.89 10.61
ROE: -- 16.37 14.21

BRIEF-Camurus Q3 operating loss widens to SEK ‍67.1​ million

* Q3 NET REVENUE SEK ‍12.5​ MILLION VERSUS SEK 30.5 MILLION YEAR AGO

26 Oct 2017

Earnings vs. Estimates